Tendo em vista os achados dos efeitos cardiovasculares causados pelo LVTVSF, tem-se como perspectivas a avaliação do LVTVSF em outras desordens cardiovasculares como em modelos de infarto agudo do miocárdio e outros modelos de hipertensão arterial tais como: modelo de hipertensão renovascular 2 rins e 1 clip e modelo de ratos geneticamente hipertensos.
Além disso, são necessários estudos sobre a participação da via PI3K/Akt no efeito vasorelaxante mediado pelo LVTVSF, assim como a
fosforilação da eNOS através da técnica de Western blot.
É importante o aprofundamento dos estudos pré-clínicos e futura realização de estudos clínicos com o LVTVSF, a fim de fortalecer a hipótese do vinho tinto do Vale de São Francisco como um alimento funcional benéfico ao aparelho cardiovascular e o desenvolvimento de um possível fitoterápico a partir deste liofilizado.
Oliveira, A. C. Avaliação pré-clínica dos efeitos cardiovasculares induzidos pelo liofilizado do vinho tinto do Vale do São Francisco em ratos -abordagem in vivo e in vitro _________________________________________________________________________________________________________________
86
REFERÊNCIAS
AJAYA, M.; GILANI, ANWAR-UL H.; MUSTAFA, M. R.Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aorta. Life Sciences, v. 74, p.603–612, 2003.
ALIOUA, A.; TANAKA, Y.; WALLNER, M.; HOFMANN, F.; RUTH, P., MEERA, P. TORO. L.The large conductance, voltage-dependent, and calcium-sensitive K+ channel, Hslo, is a target of cGMP-dependent proteinkinase phosphorylation in vivo. Journal of Biological Chemistry, v. 273. p. 32950–6, 1998.
ALTURA, B. M.; ALTURA, B. T. Differential effects of substrate depletion on drug- induced contractions of rabbit aorta. American Journal of Physiology, v. 219. p. 1698-1705, 1970.
ANGELONE, T.; PASQUA, T.; DI MAJO, D.; QUINTIERI, A. M.; FILICE, E.; AMODIO, N.; TOTA, B.; GIAMMANCO, M.; CERRA, M. C. Distinct signalling
mechanisms are involved in thedissimilar myocardial and coronary effects elicitedby quercetin and myricetin, two red wine flavonols. Nutrition, Metabolism &
Cardiovascular Diseases, v. 21. p. 362-371, 2011.
ANSELM, E.; CHATAIGNEAU, M.; NDIAYE, M.; CHATAIGNEAU,T.; SCHINI- KERTH, V. B.Grape juice causes endothelium-dependent relaxation via a redox- sensitiveSrc- and Akt-dependent activation of eNOS. Cardiovascular Research, v. 73, p. 404-413, 2007.
APPELDOORN, M. M.; VENEMA, D. P.; PETERS, T. H. F.; KOENEN, M. E.; ARTS I. C. W.; JEAN-PAUL VINCKEN, GRUPPEN, H.,KEIJER, J.; HOLLMAN, P. C. H.Some Phenolic Compounds Increase the Nitric Oxide Level in Endothelial Cells in Vitro. Journal of Agricultural and Food Chemistry, v. 57, p. 7693–7699, 2009.
ARNAL, J. F.; AMRANI, A. I.; CHATELLIER, G.; MENARD, J.; MICHEL, J. B. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension, v. 22, p. 380–387, 1993.
BATLOUNI, M. Endotélio e hipertensão arterial. Revista Brasileira de Hipertensão, v. 8, p. 328-338, 2001.
BELL, D. R.; GOCHENAUR, K. Direct vasoactive and vasoprotective properties of anthocyanin-rich extracts. Journal of Applied Physiology, v. 100, p. 1164-1170, 2006.
BIANCHINI, F.; VAINIO, H. Wine and resveratrol: mechanisms of cancer prevention European Journal of Cancer Prevention, v. 12 p. 417–425, 2003.
BOOTS, A. W.; HAENEN, G. R. M. M.; BAST, A. Health effects of quercetin: From antioxidant to nutraceutical. European Journal of Pharmacology, v. 585, p. 325- 337, 2008.
BRAYDEN, J. E.; NELSON, M. T. Regulation of arterial tone by activation of calcium- dependent potassium channels. Science, v. 256, p. 532–5, 1992.
BURNS, J.; GARDNER, P.; O’NEIL, J.; CRAWFORD, S.; MORECROFT, I.; MCPHAIL, D. B.; LISTER, C.; MATTHEWS, D.; MACLEAN, M. R.; LEAN, M., DUTHIE, G. G.; CROZIER, A. Relationship among antioxidant activity, vasodilation capacity and phenolic content of red wines. Journal of Agricultural and Food Chemistry, v. 48, p. 220– 230, 2000.
CAMPAGNOLE-SANTOS, M. J.; HAIBARA, A. S. Reflexos caridovasculares e hipertensão arterial. Revista Brasileira de Hipertensão, v. 8, p. 30-40, 2001.
CAMPBELL, W. B.; HARDER, D. R. Idenfication of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circulation Research, v. 78, p. 415- 423, 1996.
CAMPBELL, W. B.; HARDER, D. R. Prologue: EDHF—what is it. American Journal Physiology, v. 280. p. 2413–2416, 2001.
CANNON, R. O. Role of nitric oxide in cardiovascular disease: focuson the endothelium. Clinical Chemistry, v. 44, p.1809–1819, 1998.
CHATAIGNEAU, T.; NDIAYE, M.; SCHINI-KERTH, V. B. Effets vasodilatateurs des polyphénoliques du vin: role de NO et EDHF. Sang Thrombose Vaisseaux, v. 8, p.433-441, 2003.
CHEN, C.H.; WU, J. R.; YEN, M.; CHEN, Z. C. A model of medication-takingbehavior in elderly individuals with chronic disease. Journal of Cardiovascular Nursing, v. 22, p. 359–65, 2007.
CLARK, S. G.; FUCHS, L. C. Role of nitric oxide ans Ca++-dependent K+ channels in mediating heterogeneous microvascular responses to acetylcholine in different vascular bends. Journal of Pharmacology and Experimental Therapeutics, v. 282, p. 1473-1479, 1997.
Oliveira, A. C. Avaliação pré-clínica dos efeitos cardiovasculares induzidos pelo liofilizado do vinho tinto do Vale do São Francisco em ratos -abordagem in vivo e in vitro _________________________________________________________________________________________________________________
88
COGOLLUDO, A.; VIZCAÍNO-PÉREZ, F.; TAMARGO, J. New insights in the pharmacological therapy of arterial hypertension. Current Opinion in Nephrology and Hypertension, v. 14, p. 423 - 427, 2005.
COLEMAN, T. G.; MANNING, R. D. J.;NORMAN, R. A.; DECLUE, J. The Role of the Kidney in Spontaneous Hypertension. American Heart Journal, v. 89, p. 94 - 98, 1975.
COOK, N. C.; SAMMAN, S. Flavonoids-chemistry, meta-bolism, cardioprotective effects, and dietary sources. Journal Nutritional Biochemical, v. 7, p.66-76, 1996.
CORDER, R.; DOUTHWAITE, J. A.; LEES, D. M.; KHAN, N Q.; VISEU DOS
SANTOS, A. C.; WOOD, E. G.; CARRIER, M. J. Endothelin-1 synthesis reduced by red wine. Nature, v. 414, p. 863 - 864, 2001.
CORNWELL, T. L; PRYZWANSKY, K. B; WYATT, T.A; LINCOLN, T. M.Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependente protein kinase in vascular smooth muscle cells. Molecular Pharmacology, v. 40, p. 923-931, 1991.
CORRÊA, T.D.; NAMURA, J. J.; PONTES DA SILVA, C. A.; CASTRO, M. G.; MENEGHINI, A.; FERREIRA, C. Hipertensão arterial sistêmica: atualidades sobre sua epidemiologia, diagnóstico e tratamento. Systemic hypertension: latest
information on its epidemiology, diagnosis and treatment. Arquivos Medicina ABC, v. 31, p. 91-101, 2005.
COX, R. H.; LOZINSKAYA, I.; DIETZ, N. J. Calcium exerts a larger regulatory effect on potassium+ channels in small mesenteric artery mycoytes from spontaneously hypertensive rats compared to Wistar-Kyoto rats. American Journal of
Hypertension, v.16, p. 21-7, 2003.
CRIBBS, L. L. T-type Ca2+ channels in vascular smooth muscle: Multiple functions. Cell Calcium, v. 40, p. 221-230, 2006.
CUNHA, R. S; CABRAL, A. M; VASQUEZ, E. C. Evidence that autonomic nervous system plays a major role in the L-NAME-induced hypertension in conscious rats. American Journal of Hypertension, v. 6, p. 806–809, 1993.
DI, C. A.; ROTONDO, S.; IACOVIELLO, L.; DONATI, M. B.; DE GAETANO, G.Meta- analysis of wine and beer consumption in relation to vascular risk Circulation, v. 105, p.2836-2844, 2002.
DELL’AGLI, M.; BUSCIALA, A.; BOSISIO, E. Vascular effects of wine polyphenols. Cardiovascular Research, v. 63, p. 593-602, 2004.
DIEBOLT, M.; BUCHER, B.; ADRIANTSITOHAINA, R. Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression.
Hypertension, v. 38, p. 159-165, 2001.
DOGGRELL, S. A.; BROWN, L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovascular Research, v. 39 p. 89-105, 1998.
DUARTE, J.; PEREZ-PALENCIA, R.; VARGAS, F.; OCETE, M.A.; PEREZ- VIZCAINO, F., ZARZUELO, A.; et al. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. British Journal Pharmacology, v.133, p. 117-24, 2001.
ELLIOTT, W.J. Sytemic Hypertension. Current problems in cardiology, v. 32, p. 201-259, 2007.
ELLISON, R. C. Sensible drinking. The Report of an Inter-Departmental Working Group. 1995. Department of Health, United Kingdom. Decem-ber, 1995:28–34. Cited by Ellison R.C. Balancing the risks and benefits of moderate drinking. Annals of the New York Academy of Sciences, v. 957, p. 1-6, 2002.
FOLKOW, B. Physiological Aspects of Primary Hypertension. Physiological Reviews, v. 62, p. 347-504, 1982.
FURCHGOTT, R. F. Role of the endothelium in responses of vascular smoth muscles. Circulation Research, v. 53, p. 557-573, 1983.
FURCHGOTT, R. F.; ZAWADZKI, J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, v. 288, p. 373-376, 1980.
FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS– FAOSTAT. 17 may, 2011.
FURIAN, A. F.; RATTMANN, Y. D.; OLIVEIRA, M. S.; ROYES, L. F.; MARQUES, M. C., SANTOS, A. R, MELLO, C. F. Nitric oxide and potassium channels mediate GM1 ganglioside-induced vasorelaxation. Naunyn Schmiedebergs Arch
Oliveira, A. C. Avaliação pré-clínica dos efeitos cardiovasculares induzidos pelo liofilizado do vinho tinto do Vale do São Francisco em ratos -abordagem in vivo e in vitro _________________________________________________________________________________________________________________
90
FROLICH, J. D. Prostacyclin in hypertension. Journal of Hypertension.
Supplement: official journal of the International Society of Hypertension, v. 8, p. 73-78, 1990.
GARCIA-PASCUAL, A.; LABADIA, A.; JIMENEZ, E.; COSTA, G. Endothelium- dependent relaxation to acetylcholine in bovine oviductal arteries:mediation by nitric oxide and changes in apamin-sensitiveK+conductance. British Journal of
Pharmacology, v. 105, p. 429-35,1995.
GARTHWAITE, J.; SOUTHAM, E.; SBOULTON, C. L.; NIELSEN, E. B.; SCHMIDT, K.; MAYER, B. Potent and Selective Inhibition of Nitric Oxide-Sensitive Guanyly Cyclase by 1h-[1m2,3]Oxadiazolo[4,3-A]Quinoxalin-1-One. Molecular
Pharmcology, v. 48, p. 184-188, 1995.
GHATTA, S.; NIMMAGDDA, D.; XU, X.; O’FOURKE, S. T. Large-Conductance, Calcium-Activated Postassium Channels: Structural and Functional Implications. Pharmacology &Therapeutics, v. 110, p.103-116, 2006.
GROSS, S. S.; WOLIN, M. S. Nitric oxide: pathophysiological mechanisms, Annual.Review. Physiology, v. 57, p. 737-769, 1995.
GURNEY, A. M. Mechanisms of Drug-induced Vasodilation. Journal of Pharmacy and Pharmacology, v. 46, p. 242-251, 1994.
GUYENET, P. G. The sympathetic control of blood pressure. Neuroscience, v. 7, p. 335-346, 2006.
HERNANZ, R.; ALONSOB, M. J.; ZIBRANDTSENA, H.; ALVAREZ, Y.; SALAICES, M.; SIMONSENA, U. Measurements of nitric oxide concentration and hyporeactivityin rat superior mesenteric artery exposed to endotoxin. Cardiovascular Research, v. 62, p. 202–211, 2004.
HERTOG, M. G.; KROMHOUT, D.; ARAVANIS, C. BLACKBURN, H., BUZINA, R., FIDANZA, F.; GIAMPAOLI, S.; JANSEN, A.; MENOTTI, A.; NEDELJKOVIC, S. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Archives of Internal Medicine, v. 155, p. 381-386, 1995.
HIRANO, K.; HIRANO, M.; KANAIDE, H. Regulation of myosin phosphorylation and myofilament Ca2+ sensivity in vascular smooth muscle. Journal of smooth muscle research, v. 40, p. 219-236, 2004.
HILGERS, R. H.; WEBB, R. C. Reduced expression of SKCa and IKCa channel proteins in rat small mesenteric arteriesduring angiotensin II-induced hypertension. American Journal Physiology, v. 292, p. 2275-2284, 2007.
HIRSCH, R. São Francisco Valley Irrigated Fruit Production. Rabobank International, 31p. 2005.
HOU, D. Potential mechanisms of cancer chemoprevention by anthocya- nins. Current Molecular Medicine, v. 3, p. 149-159, 2003.
HU, J. P.; CALOMME, M., LASURE, A.;DE BRUYNE, T.; PIETERS, L.;
VLIETINCK, A.; BERGHE, D. A. V. Structure-activity relationship of flavonoids with superoxide scavenging activity. Biological Trace Element Research, v. 47, p. 327- 331, 1995.
IIJIMA, K.; YOSHIZUMI, M.; HASHIMOTO, M.; KIM, S., ETO, M.; AKO, J.; LIANG, Y. Q.; SUDOH, N.; HOSODA, K.; NAKAHARA, K.; TOBA, K.; OUCHI, Y. Red wine polyphenols inhibit proliferation of vascular smooth muscle cells and downregulate expression of cyclin A gene. Circulation, v.101, p. 805–11, 2000.
IIJIMA, K.; YOSHIZUMI, M.; HASHIMOTO, M.; AKISHITA, M.; KOZAKI, K.; AKO, J. WATANABE, T.; OHIKE, Y.; SON, B.; YU J.; NAKAHARA, K.; OUCHI, Y.
Red wine polyphenols inhibit vascular smooth muscle cell migration through two distinct signaling pathways. Circulation, v. 105, p. 2404–10, 2002.
IRANI, K. Oxidant signaling in vascular cell growth, death, and survival: areview of the roles of reactive oxygen species in smooth muscle andendothelial cell mitogenic and apoptotic signaling. Circulation Research, v. 87, p. 179–83, 2000.
IRIGOYEN, M. C; CONSOLIN-COLOMBO, F. M.; KRIEGER, E. M. Controle cardiovascular: regulação reflexa e papel do sistema nervoso simpático. Revista Brasileira de Hipertensão, v. 8, p. 55-62, 2001.
IRVINE, J. C.; FAVALORO, J. L.; KEMP-HARPER, B. H. Resistance Arteries Channels to Vasodilate Activates Soluble Guanylate Cyclase and K+ - NO
Hypertension, v. 41, p. 1301-1307, 2003.
JACKSON, W. F. Ion channel and vascular tone. Hypertension, v. 35, p. 173-178, 2000.
Oliveira, A. C. Avaliação pré-clínica dos efeitos cardiovasculares induzidos pelo liofilizado do vinho tinto do Vale do São Francisco em ratos -abordagem in vivo e in vitro _________________________________________________________________________________________________________________
92
JULIUS, S. Blood pressure Lowering only or more? Has the jury reached its verdict. The American Journal of Cardiology, v. 100, p. 32 – 37, 2007.
KANG, D. G.; SOHN, E. J.; LEE, Y. M.; LEE, A. S.; HAN, J. H.; KIM, T. Y.; LEE, H. S. Effects of bulbus Fritillaria water extract on blood pressure and renal functions in the L-NAME hypertensive rats. Journal of Ethnopharmacology, v. 91, p. 51-56, 2004.
KASDALLAH-GRISSA, A.; MORNAGUI, B.; AOUANI, E.; HAMMAMI, M.; EL MAY, M.; GHARBI, N.; KAMAOUN.; EL-FAZZA, S. Resveratrol, a red wine polypehol, attenuates ethanol-induced oxidative stress in rat liver. Life Science, v. 80. p. 1033- 1039, 2007.
KEARNEY, P. M.; WHELTON, M.; REYNOLDS, K.; WHELTON, P. K.; HE, J. Worldwide revalence of hypertension: a systematic review. Journal of Hypertension, v. 22, p. 11-19, 2004.
KIM, J. A.; FORMOSO, G.; LI, Y.; POTENZA, M. A; MARASCIULO, F. L.;
MONTAGNANI, M.; QUON, M. J. Epigallocatechin Gallate, a Green Tea Polyphenol, MediatesNO-dependent Vasodilation Using Signaling Pathways inVascular
EndotheliumRequiring Reactive Oxygen Speciesand Fyn. The Journal of Biological Chemistry, v. 282, p. 13736-13745, 2007.
KO, C. H.; SHEN, S. C.; LEE, T. J. F.; CHEN, Y. C. Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Molecular Cancer Therapeutic, v. 4. p. 281-290, 2005.
KOJIMA, H.; NAKATSUBO, N.; KIKUCHI, K.; KAWAHARA, S.; KIRINO, Y.;
NAGOSHI, H.; HIRATA, Y.; NAGANO, T. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins.. Analytical Chemistry, v. 70, p.2446–2453, 1998.
KOTCHEN, T. A. Controle de hipertensão. Tendências, enfoques e Metas. Hypertension, v. 49, p. 19-20, 2007.
KHOO, N. K. H.; WHITE, R.; POZZO-MILLER, L.; ZHOU, F.; CONSTANCE C.; INOUE T.; PATEL, R. P.; PARKS, D. A. Dietary flavonoid quercetin stimulates vasorelaxation in aortic vessels. Free Radical Biology & Medicine, v. 49, p. 339– 347, 2010.
KNOX, Y. M.; HAYASHI, K.; SUZUTANI, T.; OGASAWARA, M.; YOSIDA, I.; SHIINA, R.; TSUKUI, A.; TERAHARA, N.; AZUMA, M. Activity of anthocyanins from
fruit extract of Ribes Nigrum L against influenza A and B viruses. Acta Virologica, v. 45, 209-215, 2001.
LANDRAULT, N.; POUCHERET, P.; RAVEL, P.; GASC, F.; CROS, G.E.; RARD; TEISSEDRE, PIERRE-LOUIS. Antioxidant Capacities and Phenolics Levels of French Wines fromDifferent Varieties and Vintages. Journal of Agricultural and Food Chemistry, v. 49, p. 3341-3348, 2001.
LEIKERT, J.F.; RATHEL, T. R.; WOHLFART, P.; CHEYNIER, V.; VOLLMAR, A. M.; DIRSCH, V.M. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation, v. 106, p.1614-1617, 2002.
LEITE DE BARROS, A. L. B.; VIEIRA, F. S.; ASSIS, C. C.; ZEITOUN, S. S.
Alterações do nível pressórico e fatores de risco em graduandos de enfermagem. Acta Paulista de Enfermagem, v. 22, p. 773-8, 2009.
LEFÈVRE, J.; MICHAUD, S. E.; HADDAD, P.; DUSSAULT, S.; MÉNARD, C.; GROLEAU, J.; TURGEON, J.; RIVARD, A. Moderate consumption of red wine (cabernet sauvignon) improves ischemia-induced neovascularization in ApoE- deficient mice: Effect on endothelial progenitor cells and nitric oxide. The FASEB Journal, v. 21, p. 3845-52, 2007.
LÓPEZ-SEPÚLVEDA, R.; JIMÉNEZ, R.; ROMERO, M.; ZARZUELO, M. J.;
SÁNCHEZ, M.; GÓMEZ-GUZMÁN, M.; VARGAS, F.; OVALLE, F.; ZARZUELO, A.; PÉREZ-VIZCAÍNO, F.; DUARTE, J. Wine polyphenols improve endothelial function in large vessels of female spontaneously hypertensive rats. Hypertension, v. 51, p. 1- 8, 2008.
LUCENA, A. P. S.; NASCIMENTO, R. J. B.; MACIEL J.A.C.; TAVARES, J. X.; BARBOSA-FILHO, J. M.; DE OLIVEIRA, E. J. Antioxidant activity and phenolics content of selected Brazilian wines. Journal Food Composition and Analysis, v. 23, p. 30-36, 2010.
MAXWELL, S.R. Wine antioxidants and their impact in antioxidant function in vivo. Wine and Therapeutics Benefits. American Chemical Society, Washington.1997.
MERAL, C. Antioxidant effects of wine polyphenols.Trakia Journal Science, v. 6. p. 57-62, 2008.
MIRA, N.V.M.; BARROS, R.M.C.; SCHIOCCHET, M.A.; NOLDIN, J.A.; LANFER- MARQUEZ, U.M. Extração, análise e distribuição dos ácidos fenólicos em genótipos pigmentados e não pigmentados de arroz (Oryza sativa L.). Ciência e Tecnologia dos Alimentos, v. 4, p. 994-1002, 2008.
Oliveira, A. C. Avaliação pré-clínica dos efeitos cardiovasculares induzidos pelo liofilizado do vinho tinto do Vale do São Francisco em ratos -abordagem in vivo e in vitro _________________________________________________________________________________________________________________
94
MONCADA, S.; VANE, J. R. Pharmacology and endogenous roles of prostaglandins endoperoxydes, thomboxone A2 and prostacyclin. Pharmacological Reviews, v. 30, p. 293-331, 1979.
MONCADA, S.; PALMER, R. M.; HIGGS, E. A. Nitric oxide: physiology,
pathophysiology and pharmacology, Pharmacological Reviews, v. 43, p. 109-142, 1991.
MONCADA, S.; HIGGS, E. A. The L-arginine - nitric oxide pathway. New England Journal of Medicine, v. 29, p. 2002-2012, 1993.
MOURA, R. S.; MIRANDA, D. Z.; PINTO, A. C. A.; SICCA, R. F.; SOUZA, M. A. V.; RUBENICH, L. M. S.; CARVALHO, L. C. R. M.; RANGEL, B. M.; TANO, T.;
MADEIRA, S. V. F.; REZENDE, A. C. Mechanism of endothelium-dependent vasodilation and the antihypertensive effect of brazilian red wine. Journal of Cardiovascular Pharmacology, v. 44, p. 302-309, 2004.
MUKAMAL, K. J.; MACLURE, M.; MULLER, J. E.; SHERWOOD, J. B.; MITTLEMAN, M. A.Tea consumption and mortality after acute myocardial infarction. Circulation, v. 105, p. 2476–2481, 2002.
MULLERSHAUSEN, F.; FRIEBE, A.; FEIL, R.; THOMPSON, W. J.; HOFMANN, F.; KOESLING, D. Direct Activtion of PDE5 by gmp: Long-Term Effects Within
NO/cGMP Signialing. Journal Cell Biological, v. 160, p. 719-727, 2003.
NAVARRO, J.; SANCHEZ, A.; SÁIZ, J.; RUILOPE, L. M.; GARCIA-ESTAN, J.; ROMERO, J. C.; MONCADA, S.; LAHERA, V. Hormonal, renal, and metabolic
alterations during hypertension induced by chronic inhibition of NO in rats. American Journal of Physiology, v. 267, p.1516–1521, 1994.
NAVARRO-ANTOLIN, J.; LAMAS, S. Nitrosative stress by cyclosporine A in the endothelium: studies with the NO-sensitive probe diaminofluorescein-2/diacetate using flow cytometry. Nephrology Dialysis Transplantation, v. 16, p. 1 6–9, 2001.
NDIAYE, M.; CHATAIGNEAU, T.; ANDRIANTSITOHAINA, R.; JEAN-CLAUDE STOCLET; SCHINI-KERTH, V. B. Red wine polyphenols cause endothelium- dependent EDHF-mediated relaxations in porcine coronary arteriesvia a redox- sensitive mechanism. Biochemical and Biophysical Research Communications, v. 310, p. 371–377, 2003.
NDIAYE, M.; CHATAIGNEAU, T.; CHATAIGNEAU, M.; SCHINI-KERTH, V. B..Red wine polyphenols induce EDHF-mediated relaxationsin porcine coronary arteries
through the redox-sensitiveactivation of the PI3-kinase/Akt pathway. British Journal of Pharmacology, v. 142, p.1131-1136, 2004.
NDIAYE, M.; CHATAIGNEAU, M.; LOBYSHEVA, I.; CHATAIGNEAU, T.; SCHINI- KERTH, V.B. Red wine polyphenol-induced, endothelium-dependent NO-mediated relaxation is due to the redox-sensitive PI3-kinase/Akt-dependent phosphorylation of endothelial NO-synthase in the isolatedporcine coronary artery. The FASEB
Journal, v. 19, p. 455-7, 2005.
NIJVELDT, R. J.; VAN N. E.; VAN H. D. E.; et al. Flavonoids: a review of probable mechanisms of action and potential applications. American Journal of Clinical Nutrition, v. 74. p. 418-425, 2001.
ONO, K.; NAKANE, H.; FUKUSHIMA, M.; CHERMANN, J. C.; BARRE `-SINOUSSI F. Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. European Journal of Biochemistry, v. 190. p. 469-76, 1990.
OPIE, L.H.; LECOUR, S. The red wine hypothesis: from concepts to protective signaling molecules. European Heart Journal, v. 28, p. 1683-1693, 2007.
PADILLA, E.; RUIZ, E.; REDONDO, S.;GORDILLO-MOSCOSOA, A., SLOWING, K., TEJERINA, T. Relationship between vasodilation capacity and phenolic content ofSpanish wines. European Journal of Pharmacology, v. 517, p. 84-91, 2005. PAGE, C. P.; CYRTIS, M. J. C.; SUTTIER, M. C.; WALKER, M. J. A.; HOFFAMANN, B. B. As drogas e o sistema cardiovascular. Farmacologia integrada, 1ª ed., Editora Manole, São Paulo-SP. p. 153-193, 1999.
PAPAZAFIROPOULOU, A.; SKLIROS, E.; SOTIROPOULOS, A.; PAPAFRAGOS, C.; GIKAS, A.; APOSTOLOU, O.; KALIORA, H.; TOUNTAS, C. Prevalence of target organ damage in hypertensive subjects attending primary care: C.V.P.C. study (Epidemiological Cardio-Vascular Study in Primary Care), BMC Family Practice, v. 12. p. 75, 2011.
PAIXÃO, N.; PERESTRELO, R.; MARQUESA, J. C.; CÂMARA, J.S. Relationship between antioxidant capacity and total phenolic content of red, rosé and white wines. Food Chemistry, v. 105, p. 10, 2007.
PIMENTEL, A. M. L.; COSTA, C. A.; CARVALHO, L. C. R. M.; BRANDÃO, R. M.; RANGEL, B. M.; TANO,T.; SOARES DE MOURA, R.; RESENDE, A.C. The role of NO-GMPc pathway and potassium channels on the relaxation induced by clonidine in the rat mesenteric arterial bed. Vascular Pharmacology, v. 46, p. 353-359, 2007.
Oliveira, A. C. Avaliação pré-clínica dos efeitos cardiovasculares induzidos pelo liofilizado do vinho tinto do Vale do São Francisco em ratos -abordagem in vivo e in vitro _________________________________________________________________________________________________________________
96
RESS, D. D.; PALMER, R. J. M.; SCHULZ, R.; HODSON, H. F.; MONCADA, S. Characterization of three inhibitors of endothelial nitric oxide synthase in vivo and in vitro. British Journal of Pharmacology, v. 101, p. 746-752, 1990.
RICE-EVANS, C.A.; MILLER, N.J.; BOLWELL, P.G.; BRAMLEY, P.; PRIDHAM, J.B. The relative antioxidant activities of plant-derived polyphenolicflavonoids. Free Radical Research, v. 22, p. 375-383, 1995.
ROBAK, J.; GRYGLEWSKI, R. J. Flavonoids are scavengers ofsuperoxide anions. Biochemical Pharmacology, v. 37, p. 837-841, 1988.
ROBICHAUD, J. L.; NOBLE, A. C. Astringency and bitterness of selected phenolics in wine. Journal of the Science of Food and Agricultura, v. 53, p.343-353, 1990.
RODRIGUE, C. M.; AROUS, N.; BACHIR, D.; SMITH-RAVIN J.; ROMEO, P. H. Resveratrol, a natural dietary phytoalexin, possesses similar properties to
hydroxyurea towards erythroid differantiation. British Journal of Haematology, v. 113, p. 500-507, 2001.
ROSSI, A.; SERRAINO, I.; DUGO, P.; DIPAOLA, R.; MONDELLO, L.; GENOVESE, T.; MORABITO, D.; DUGO, G.; SAUTEBIN, L.; CAPUTI, A. P.; CUZZEREA, S. Protective effects of anthocyanins from blackberry in a rat model of acute lung inflammation. Free radical research, v. 37, p. 891-900, 2003.
SABRANE, K.; GAMBARYAN, S.; BRANDES, R. P.; HOLTWICK, R.; VOSS, M.; KUHN, M. Increased Sensitivity to Endothelial Nitric Oxide (NO) Contributes to Arterial Normotension in Mice with Vascular Smooth Muscle selective Deletion of the Atrial Natriuretic Peptide (ANP) Receptor. The Journal of Biological Chemistry, v. 278, 16, p. 17963–17968, 2003.
SAFAR, M. E.; PERONNEAU, P. P.; LEVENSON, J. A.; TOTO-MOUKOUO, J. A.; SIMON, A. C. Pulsed Doppler: Diameter, Blood Flow Velocity and Volumic Flow of the Brachial Artery in Sustained Essential Hypertension. Circulation, v.63, p.393- 400, 1981.
SAWAYER, D. B.; BYMASTER, P. F.; CALLIGARO, O. D.;FALCONE, J.; MITCH, H. C.; WARD, S. J.; WHITESITT, C.; SHANNON, E. H. Direct pharmacological
comparison of the muscarinc receptors mediating relaxation and contraction in the rabbit thoracic aorta. General Pharmacology, v. 32, p. 445-452, 1999.
SCATENA, R.; BOTTONI, P.; PONTOGLIO, A.; GIARDINA, B. Pharmacological modulation of nitric oxide release: new pharmacological perspectives, potential benefits and risks. Current Medicinal Chemistry, v. 17, p. 61-73, 2010.
SCHINI-KERTH, V. B.; AUGER, C.; JONG-HUN, K.; ÉTIENNE-SELLOUM, N.; CHATAIGNEAU, T. Nutritional improvement of the endothelial control
of vascular tone by polyphenols: role of NO and EDHF. Pflügers Archiv - European Journal of Physiology, v. 459, p. 853-862, 2010.
SOBEY, C.G. Potassium Channel Function in Vascular Disease. Arteriosclerosis, Thrombsis and Vascular Biology, v. 21, p.28-38, 2001.
SOCIEDADE BRASILEIRA DE CARDIOLOGIA / SOCIEDADE BRASILEIRA DE HIPERTENSÃO / SOCIEDADE BRASILEIRA DE NEFROLOGIA. VI Diretrizes Brasileiras de Hipertensão. Arquivos Brasileiros de Cardiologia, v. 95, p. 1-5, 2010.
SOFI, F.; CESARI, F., ABBATE,R. et al. Adherence to Mediterranean diet and health status: meta-analysis. British Medical Journal, v. 337 p. 1344, 2008.
SOLER, E. P.; RUIZ, V. C. Epidemiology and Risk Factors of Cerebral Ischemia and Ischemic Heart Diseases: Similarities and Differences. Current Cardiology
Reviews, v. 6, p. 138-149, 2010.
STOCLET, J. C.; CHATAIGNEAU, T.; NDIAYE, M.; OAK, M. H.; BEDOUI, J. E.; CHATAIGNEAU, M.; SCHINI-KERTH, V.B. Vascular protection by dietary polyphenols. European Journal of Pharmacology, v. 500, p. 299-313, 2004.
TANAKA,Y.; MOCHIZUKI, Y.; SHIGENOBU, K. Significant role of neuronal non-N- type calcium channels in the sympathetic neurogenic contraction of rat mesenteric. British Journal of Pharmacology, v. 128. p. 1602-1608, 1999.
TAHVANAINEN, A.; TAURIO, J.; MÄKI-JOUPPI, J.; KÖÖBI, P.; MUSTONEN, J.; KÄHÖNEN,M.; SAND, J.; NORDBACK, I.; PÖRSTI, I. Increased wall tension in response to vasoconstrictors in isolated mesenteric arterial rings from patients with high blood pressure. Basic & Clinical Pharmacology & Toxicology, v. 99, p. 440- 449, 2006.
TAKESHITA, A.; MARK, A. L. Decreased Venous Distensibility in Boderline Hypertension. Hypertension, v.1, p.202-206, 1979.
TONIETTO, J. Valorização Do Ecossistema. Importância da Regionalização
Vitivinícola na Produção de Vinhos de Qualidade. VIII Viticulture and Encology Latin- American Congress. Montevideo, Uruguay, nov. 2001.
TOREL, J.; CILLARD, J.; CILLARD, P. Antioxidant activity offlavonoids and reactivity with peroxy radical. Phytochemistry, v. 25, p. 383–385, 1986.
Oliveira, A. C. Avaliação pré-clínica dos efeitos cardiovasculares induzidos pelo liofilizado do vinho tinto do Vale do São Francisco em ratos -abordagem in vivo e in vitro _________________________________________________________________________________________________________________
98
TIWARI, R.; MOHAN, M.; KASTURE, S.; MAXIA, A.; BALLERO, M. Cardioprotective potential of Myricetin in isoproterenol-induced myocardial infarction in wistar rats. Phytother Research [Epub ahead of print]. 2009.
TSUDA, T.; HORIO, F.; UCHIDA, K.; AOKI, H.; OSAWA, T. Dietary cyanidin 3-O- -D-glucoside- rich purple color prevents obesity and ameliorates hyperglycemia in mice. Journal of Nutrition, v. 133, p. 2125-2130, 2003.
TZENG, S. H.; KO, W. C.; KO, F. N.; TENG, C. M. Inhibition of plateled aggregation by some flavonoids.Thrombosis Research, v. 64 p. 91-100, 1991.
USUI, M.; EGASHIRA, K.; KITAMOTO, S., et al. Pathogenic role of oxidative stressin vascular angiotensin-converting enzyme activation in long-termblockade of nitric oxide synthesis in rats. Hypertension, v. 34. p. 546–551, 1999.
VANHOUTTE, P. M. COX-1 and Vascular Disease. Clinical. Pharmacology and Therapeutics, v. 86, p.212–215, 2009.
VANHOUTTE, P. M.; BOULANGER, C. M. Function the endothelium in arterial hypertension. La Revue Du Praticien, v. 45, p. 2513-2518, 1995.
VIRDIS, A.; COLUCCI, R.; VERSARI, D.; GHISU, N.; FORNAI, M.; ANTONIOLI, L.; DURANTI, E.; DAGHINI, E.; GIANNARELLI, C.; BLANDIZZI, C.; TADDEI, S.; TACCA, M. D. Atorvastatin Prevents Endothelial Dysfunction in Mesenteric Arteries From Spontaneously Hypertensive Rats Role of Cyclooxygenase 2–Derived
Contracting Prostanoids. Hypertension, v. 53. p. 1008-1016, 2010.
VOGALIS, F.; ZHANG, Y.; GOYAL, R. K. An intermediate conductance K+ channel in the cell membrane of mouse intestinal smooth musucle. Biochimica et Biophysica Acta v. 1371, p. 309-16, 1998.
VUORINEN, H.; MÄÄTTÄ, K.; TÖRRÖNEN, R. Content of the flavonols myricetin, quercetin and kaempferol in finnish berry wines. Journal of Agricultural and Food Chemistry, n. 48, p. 2675-2680, 2000.
WINK, D. A.; MITCHELL, J. B. Chemical biology of nitric oxide: Insights intoregulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide, Free Radical. Biology and Medicine, v. 25. p. 434–456, 1998.
WOLLIN, S. D.; JONES, P. J. H. Alcohol, red wine and cardiovascular disease. Journal of Nutrition, v. 131 p. 1401-1404, 2001.